To include your compound in the COVID-19 Resource Center, submit it here.

Rapidscan Pharma Solutions Inc., General Electric sales and marketing update

Rapidscan granted General Electric exclusive co-commercialization rights to Rapiscan regadenoson in the U.K.

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE